Rain Therapeutics Inc. Contracts & Agreements
36 Contracts & Agreements
- Business Finance (11 contracts)
- Business Operations (1)
- Human Resources (13)
- Intellectual Property (3)
- Real Estate (4)
- Uncategorized (4)
- Notice of Lease Terms, effective as of July 26, 2023, between the Registrant and BSP Senita 8000 Jarvis, LLC (Filed With SEC on November 9, 2023)
- Rain Oncology Inc. Amended and Restated Executive Severance Plan (Filed With SEC on November 9, 2023)
- Form of Director 2021 Equity Incentive Plan Grant Notice for Nonqualified Stock Options (One Year Vesting) (Filed With SEC on May 11, 2023)
- Form of Director 2021 Equity Incentive Plan Grant Notice for Nonqualified Stock Options (Three Year Vesting) (Filed With SEC on May 11, 2023)
- Form of Employee 2021 Equity Incentive Plan Grant Notice for Nonqualified Stock Options (Filed With SEC on May 11, 2023)
- Form of Employee 2021 Equity Incentive Plan Grant Notice for Incentive Stock Options (Filed With SEC on May 11, 2023)
- Form of Employee 2021 Equity Incentive Plan Grant Notice for Restricted Stock Unit Award (Filed With SEC on May 11, 2023)
- Third Amendment to Office Lease Agreement, dated March 16, 2023, between the Registrant and BSP Senita 8000 Jarvis, LLC (Filed With SEC on May 11, 2023)
- First Amendment to Rain Oncology Inc. 2021 Equity Incentive Plan (Filed With SEC on March 9, 2023)
- First Amendment to Rain Oncology Inc. Amended and Restated 2018 Stock Option/Stock Issuance Plan (Filed With SEC on March 9, 2023)
- First Amendment to Rain Oncology Inc. 2021 Employee Stock Purchase Plan (Filed With SEC on March 9, 2023)
- Second Amendment to Office Lease Agreement, dated October 4, 2022, between the Registrant and BSP Senita 8000 Jarvis, LLC (Filed With SEC on March 9, 2023)
- Underwriting Agreement, dated November 3, 2022, by and between Rain Therapeutics Inc. and Guggenheim Securities, LLC (Filed With SEC on November 7, 2022)
- First Amendment to Underwriting Agreement, dated November 4, 2022, by and between Rain Therapeutics Inc. and Guggenheim Securities, LLC (Filed With SEC on November 7, 2022)
- Amendment to License Agreement dated June 29, 2022, between the Registrant and Daiichi Sankyo Company Limited (Filed With SEC on August 4, 2022)
- Form of Employee 2021 Equity Incentive Plan Grant Notice for Nonqualified Stock Options (Filed With SEC on August 4, 2022)
- Form of Director 2021 Equity Incentive Plan Grant Notice for Nonqualified Stock Options (Filed With SEC on August 4, 2022)
- Description of Securities (Filed With SEC on March 3, 2022)
- Rain Therapeutics Inc. Executive Severance Plan and Form of Participation Agreement (Filed With SEC on August 17, 2021)
- 2021 Equity Incentive Plan (Filed With SEC on April 19, 2021)
- 2021 Employee Stock Purchase Plan (Filed With SEC on April 19, 2021)
- Exchange Agreement, dated April 17, 2021, by and among the Registrant and the stockholders listed therein (Filed With SEC on April 19, 2021)
- Form of Underwriting Agreement (Filed With SEC on April 9, 2021)
- Form of Common Stock Certificate of the Registrant (Filed With SEC on April 9, 2021)
- Form of Exchange Agreement by and among the Registrant and the stockholders listed therein (Filed With SEC on April 9, 2021)
- Amended and Restated Investors Rights Agreement, dated September 2, 2020, by and among the Registrant and certain of its stockholders (Filed With SEC on April 2, 2021)
- Form of Indemnification Agreement for directors and executive officers (Filed With SEC on April 2, 2021)
- Amended and Restated 2018 Stock Option/Stock Issuance Plan and form of award agreement thereunder (Filed With SEC on April 2, 2021)
- Director Offer Letter, dated March 19, 2018, by and between the Registrant and Tran Nguyen (Filed With SEC on April 2, 2021)
- Director Offer Letter, dated March 19, 2018, by and between the Registrant and Peter Radovich (Filed With SEC on April 2, 2021)
- Employment Agreement, dated September 10, 2020, by and between the Registrant and Avanish Vellanki (Filed With SEC on April 2, 2021)
- Employment Agreement, dated September 10, 2020, by and between the Registrant and Robert Doebele (Filed With SEC on April 2, 2021)
- Offer Letter, dated October 1, 2020, by and between the Registrant and Nelson Cabatuan (Filed With SEC on April 2, 2021)
- License Agreement, dated September 2, 2020, between the Registrant and Daiichi Sankyo Company, Limited (Filed With SEC on April 2, 2021)
- Intellectual Property License Agreement, dated July 30, 2020, by and between the Registrant and Drexel University (Filed With SEC on April 2, 2021)
- Office Lease Agreement, dated September 25, 2018, between the Registrant and BSP Senita 8000 Jarvis, LLC, as amended (Filed With SEC on April 2, 2021)
